23andMe Holding Co. (ME)
NASDAQ: ME · IEX Real-Time Price · USD
0.442
-0.032 (-6.79%)
At close: Jul 19, 2024, 4:00 PM
0.455
+0.013 (2.87%)
Pre-market: Jul 22, 2024, 7:23 AM EDT
23andMe Holding Co. Market Cap
23andMe Holding Co. has a market cap or net worth of $223.75 million as of July 22, 2024. Its market cap has decreased by -70.24% in one year.
Market Cap
223.75M
Enterprise Value
82.38M
1-Year Change
-70.24%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since October 2, 2020, 23andMe Holding Co.'s market cap has decreased from $495.50M to $223.75M, a decrease of -54.84%. That is a compound annual growth rate of -18.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 216.70M | -50.46% |
| Dec 29, 2023 | 437.40M | -55.54% |
| Dec 30, 2022 | 983.80M | -63.74% |
| Dec 31, 2021 | 2.71B | 267.19% |
| Dec 31, 2020 | 739.00M | 49.14% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Delcath Systems | 228.68M |
| ESSA Pharma | 228.03M |
| Aldeyra Therapeutics | 226.96M |
| Acrivon Therapeutics | 226.33M |
| Butterfly Network | 225.46M |
| Zura Bio | 222.48M |
| Molecular Partners AG | 218.37M |
| Inogen | 218.09M |